EP3344064A4 - Kits et procédés d'utilisation d'enzymes pour modifier des charges polysaccharidiques et des systèmes d'administration - Google Patents

Kits et procédés d'utilisation d'enzymes pour modifier des charges polysaccharidiques et des systèmes d'administration Download PDF

Info

Publication number
EP3344064A4
EP3344064A4 EP16769585.7A EP16769585A EP3344064A4 EP 3344064 A4 EP3344064 A4 EP 3344064A4 EP 16769585 A EP16769585 A EP 16769585A EP 3344064 A4 EP3344064 A4 EP 3344064A4
Authority
EP
European Patent Office
Prior art keywords
kits
enzymes
loads
methods
delivery systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16769585.7A
Other languages
German (de)
English (en)
Other versions
EP3344064A1 (fr
Inventor
Leonard B. MILLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Aesthetic Technologies Inc
Original Assignee
Advanced Aesthetic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Aesthetic Technologies Inc filed Critical Advanced Aesthetic Technologies Inc
Publication of EP3344064A1 publication Critical patent/EP3344064A1/fr
Publication of EP3344064A4 publication Critical patent/EP3344064A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0039—Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP16769585.7A 2015-03-24 2016-03-23 Kits et procédés d'utilisation d'enzymes pour modifier des charges polysaccharidiques et des systèmes d'administration Withdrawn EP3344064A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137558P 2015-03-24 2015-03-24
PCT/US2016/023726 WO2016154277A1 (fr) 2015-03-24 2016-03-23 Kits et procédés d'utilisation d'enzymes pour modifier des charges polysaccharidiques et des systèmes d'administration

Publications (2)

Publication Number Publication Date
EP3344064A1 EP3344064A1 (fr) 2018-07-11
EP3344064A4 true EP3344064A4 (fr) 2019-08-07

Family

ID=56978996

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16769585.7A Withdrawn EP3344064A4 (fr) 2015-03-24 2016-03-23 Kits et procédés d'utilisation d'enzymes pour modifier des charges polysaccharidiques et des systèmes d'administration

Country Status (2)

Country Link
EP (1) EP3344064A4 (fr)
WO (1) WO2016154277A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3582749A4 (fr) * 2017-02-18 2020-12-30 Advanced Aesthetic Technologies, Inc. Kits et procédés d'utilisation d'hyaluronidase pour modifier des charges polysaccharidiques et systèmes d'administration

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032483A2 (fr) * 2003-10-01 2005-04-14 Momenta Pharmaceuticals, Inc. Polysaccharides pour l'administration pulmonaire d'agents actifs
US20060067927A1 (en) * 2004-06-29 2006-03-30 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
KR20130085017A (ko) * 2012-01-18 2013-07-26 고려대학교 산학협력단 3,6-안하이드로-l-갈락토오스의 제조방법 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007019554A2 (fr) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides destines a l'administration de principes actifs
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
ITMI20130507A1 (it) * 2013-04-04 2014-10-05 Ghimas Spa Composizione riempitiva (filler) per il trattamento di lipoatrofie

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032483A2 (fr) * 2003-10-01 2005-04-14 Momenta Pharmaceuticals, Inc. Polysaccharides pour l'administration pulmonaire d'agents actifs
US20060067927A1 (en) * 2004-06-29 2006-03-30 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
KR20130085017A (ko) * 2012-01-18 2013-07-26 고려대학교 산학협력단 3,6-안하이드로-l-갈락토오스의 제조방법 및 이의 용도

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C. H. LEE ET AL: "A Novel Agarolytic -Galactosidase Acts on Agarooligosaccharides for Complete Hydrolysis of Agarose into Monomers", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 80, no. 19, 1 October 2014 (2014-10-01), US, pages 5965 - 5973, XP055332562, ISSN: 0099-2240, DOI: 10.1128/AEM.01577-14 *
LEE CHAN HYOUNG ET AL: "Saccharification of agar using hydrothermal pretreatment and enzymes supplemented with agarolytic [beta]-galactosi", PROCESS BIOCHEMISTRY, vol. 50, no. 10, 22 June 2015 (2015-06-22), pages 1629 - 1633, XP029265129, ISSN: 1359-5113, DOI: 10.1016/J.PROCBIO.2015.06.017 *
See also references of WO2016154277A1 *
YAMADA TANIGUCHI AKIKO ET AL: "Purification and properties of beta-galactosidase from Tilapia intestine: Digestive enzyme of Tilapia-X", FISHERIES SCIENCE, vol. 70, no. 4, 1 August 2004 (2004-08-01), JP, pages 688 - 694, XP093062851, ISSN: 0919-9268, DOI: 10.1111/j.1444-2906.2004.00858.x *

Also Published As

Publication number Publication date
EP3344064A1 (fr) 2018-07-11
WO2016154277A1 (fr) 2016-09-29

Similar Documents

Publication Publication Date Title
IL272367A (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
EP3727469A4 (fr) Nouveaux systèmes et enzymes crispr
EP3298168A4 (fr) Agents réducteurs stabilisés et leurs procédés d'utilisation
EP3362032A4 (fr) Systèmes et procédés de fabrication et d'utilisation de microsphères de gel
IL256369A (en) Novel crispr enzymes and systems
MA47849A (fr) Anticorps anti-gitr et leurs procédés d'utilisation
MA42447A (fr) Anticorps anti-pd-1, anticorps anti-pd-1 activables, et leurs procédés d'utilisation
EP3358940A4 (fr) Systèmes et procédés de culture
EP3313404A4 (fr) Compositions thérapeutiques, associations et procédés d'utilisation
EP3390624A4 (fr) Polypeptides de modification ciblée modifiés et leurs procédés d'utilisation
EP3322297A4 (fr) Procédés d'administration et compositions pour génie génomique médié par nucléase
EP3291765A4 (fr) Procédés d'administration d'un agent à l'oeil
PL3256594T3 (pl) Ulepszone dostarczanie cząstek wirusa do prążkowia i kory
EP3302053A4 (fr) Compositions et procédés pour l'administration d'un polynucléotide dans une plante
MA55097A (fr) Oxystérols et leurs procédés d'utilisation
MA41044A (fr) Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer
EP2988786A4 (fr) Compositions et procédés d'utilisation pour l'administration sélective de médicaments
EP3435956A4 (fr) Compositions photo-stabilisées et leurs procédés d'utilisation
EP3307321A4 (fr) Plate-forme d'anticorps multi-spécifiques et procédés associés
EP3307894A4 (fr) Systèmes d'administration viraux non intégratifs et procédés d'utilisation associés
MA42409A (fr) Oxystérols et leurs procédés d'utilisation
EP3538071A4 (fr) Procédés et systèmes de composition pharmaceutique
EP3490569A4 (fr) Compositions topiques et ses procédés d'utilisation
MA54851A (fr) Oxystérols et leurs procédés d'utilisation
MA40998A (fr) Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20190705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/73 20060101ALI20190701BHEP

Ipc: A61Q 19/08 20060101ALI20190701BHEP

Ipc: A61K 47/36 20060101ALI20190701BHEP

Ipc: C08B 37/00 20060101ALI20190701BHEP

Ipc: A61K 31/167 20060101ALI20190701BHEP

Ipc: A61K 9/00 20060101ALI20190701BHEP

Ipc: A61K 8/66 20060101ALI20190701BHEP

Ipc: A23K 20/168 20160101ALI20190701BHEP

Ipc: A23K 20/195 20160101AFI20190701BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230718

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250805